Stock XLO XILIO THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Xilio Therapeutics, Inc.

Equities

XLO

US98422T1007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
1.14 USD +5.56% Intraday chart for Xilio Therapeutics, Inc. -3.39% +107.27%
May. 14 Xilio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 19 Gilead Sciences Likely to Record IPR&D Hit on Q1 Non-GAAP Earnings, Oppenheimer Says MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
XILIO THERAPEUTICS, INC.
Other Biotechnology & Medical Research
+5.56%-3.39%+107.27%-64.26% - 42.07M
Neutral
Bullish
Bearish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. XLO Stock
  4. Charts Xilio Therapeutics, Inc.
  5. Comparison Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW